Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | P2RX4 | Q99571 | 6/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20199992 | 1.00 | MAPT (0.40) | MAPTSMN1; SMN2NPSR1P2RX4MEN1 | |
| SCHEMBL31346510 | 0.98 | MAPT (0.41) | MAPTSMN1; SMN2NPSR1P2RX4MEN1 | |
| SCHEMBL15489932 | 0.98 | MAPT (0.41) | MAPTSMN1; SMN2NPSR1P2RX4MEN1 | |
| SCHEMBL22958700 | 0.97 | MAPT (0.38) | MAPTSMN1; SMN2NPSR1P2RX4ALDH1A1 | |
| SCHEMBL22958702 | 0.95 | MAPT (0.37) | MAPTSMN1; SMN2NPSR1P2RX4MEN1 | |
| SCHEMBL23733545 | 0.95 | MAPT (0.39) | MAPTSMN1; SMN2NPSR1P2RX4MEN1 | |
| SCHEMBL20199998 | 0.94 | MAPT (0.36) | MAPTSMN1; SMN2NPSR1P2RX4MEN1 | |
| SCHEMBL22958649 | 0.93 | ALDH1A1 (0.36) | MAPTSMN1; SMN2NPSR1MEN1ALDH1A1 | |
| SCHEMBL19038404 | 0.93 | ALDH1A1 (0.36) | MAPTSMN1; SMN2NPSR1MEN1ALDH1A1 | |
| SCHEMBL20199989 | 0.92 | MAPT (0.35) | MAPTSMN1; SMN2NPSR1P2RX4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11088207-B2 | Solid-state image sensor, photoelectric conversion film, electron blocking layer, imaging apparatus, and electronic device | SONY SEMICONDUCTOR SOLUTIONS CORPORATION (JP) | 2021-08-10 | — | — | US | disclosed |
| US-20180151625-A1 | SOLID-STATE IMAGE SENSOR, PHOTOELECTRIC CONVERSION FILM, ELECTRON BLOCKING LAYER, IMAGING APPARATUS, AND ELECTRONIC DEVICE | SONY SEMICONDUCTOR SOLUTIONS CORPORATION (JP) | 2018-05-31 | — | — | US | disclosed |
| US-20180151625-A1 | SOLID-STATE IMAGE SENSOR, PHOTOELECTRIC CONVERSION FILM, ELECTRON BLOCKING LAYER, IMAGING APPARATUS, AND ELECTRONIC DEVICE | SONY SEMICONDUCTOR SOLUTIONS CORPORATION (JP) | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180151625-A1 | SOLID-STATE IMAGE SENSOR, PHOTOELECTRIC CONVERSION FILM, ELECTRON BLOCKING LAYER, IMAGING APPARATUS, AND ELECTRONIC DEVICE | EMC1, EMC2, ESR1 | MAPT 1073/4885SMN1; SMN2 3905/4885NPSR1 4771/4885 |
| US-11088207-B2 | Solid-state image sensor, photoelectric conversion film, electron blocking layer, imaging apparatus, and electronic device | EMC1, EMC2, ESR1 | MAPT 1073/4885SMN1; SMN2 3905/4885NPSR1 4771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.